Pulse Biosciences Inc Beta
What is the Beta of Pulse Biosciences Inc?
The Beta of Pulse Biosciences Inc is 2.00
What is the definition of Beta?
BETA indicates whether a stock is more or less volatile than the market as a whole. A beta less than 1 indicates that the stock is less volatile than the market, while a beta more than 1 indicates that the stock is more volatile. Volatility is measured as the fluctuation of the price around the mean.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta of companies in the Health Care sector on NASDAQ compared to Pulse Biosciences Inc
What does Pulse Biosciences Inc do?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Companies with beta similar to Pulse Biosciences Inc
- Walker River Resources has Beta of 2.00
- Advanced Industries has Beta of 2.00
- Fossil Inc has Beta of 2.00
- Galeo Concept SA has Beta of 2.00
- HIT Technologies has Beta of 2.00
- Arista Networks Inc has Beta of 2.00
- Pulse Biosciences Inc has Beta of 2.00
- BerGenBio ASA has Beta of 2.00
- ams AG has Beta of 2.00
- ams AG has Beta of 2.00
- M8 Sustainable has Beta of 2.00
- Basler Aktiengesellschaft has Beta of 2.00
- Cardlytics Inc has Beta of 2.00